#$%^&*AU2015202618B220161006.pdf#####Abstract The invention relates to methods of reducing the risk or preventing the occurrence of an adverse event 9AE) or a serious adverse event (SAE) in patients scheduled to undergo treatment with nitric oxide inhalation, by excluding patients who have pre-existing left ventricular.